Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 treatment study for abnormal uterine bleeding
PACTR202310719625892Phase 1Recruiting
- Sponsor
- Avana Health
- Start
- Dec 2023
- Countries
- 1
01
Overview
Phase 1, randomised trial in menstrual disorders, sponsored by Avana Health. Primary endpoints: Solicited adverse events and Unsolicited outcomes. Started Dec 2023; status: recruiting.
02
Conditions
menstrual disorders
Beyond the preview
Go deeper on PACTR202310719625892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202310719625892.